{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiewt7uknugkme5laa6brvqpfhgox3tdr44emy7kzqqcluegvptxfq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjmu4s6i3tu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie2f5d4kuoqjutowsc6uyc7dijbxkvbkic5ngnhueuwmq2picce4e"
    },
    "mimeType": "image/jpeg",
    "size": 85880
  },
  "path": "/2026/04/16/biotech-news-cochrane-review-reignites-alzheimers-amyloid-war/?utm_campaign=rss",
  "publishedAt": "2026-04-16T15:18:54.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "Another Elevidys trial, FDA reconsiders peptides, and other biotech news from The Readout",
  "title": "STAT+: Cochrane review reignites Alzheimer’s amyloid wars",
  "updatedAt": "2026-04-16T15:19:00.000Z"
}